[Treatment of scleroderma].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003911:Dextrans / Q000627:therapeutic use; D004492:Edetic Acid / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use; D008297:Male; D012594:Scleroderma, Localized / Q000188:drug therapy*; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D013565:Sympatholytics / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000317:Adrenergic alpha-Antagonists; D000962:Antimalarials; D003911:Dextrans; D013565:Sympatholytics; D004492:Edetic Acid; D006821:Hyaluronoglucosaminidase; D001379:Azathioprine
Zur Behandlung der Sklerodermien.